Racial disparities in COVID-19 test positivity among people living with HIV in the United States.
COVID-19
Immunosuppression
SARS-CoV-2 virus
racial ethnic disparities
social determinants of health
Journal
International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
pubmed:
22
3
2022
medline:
9
4
2022
entrez:
21
3
2022
Statut:
ppublish
Résumé
This study aimed to compare COVID-19 positivity by HIV status and race/ethnicity using data from the U.S. National COVID Cohort Collaborative (N3C). The N3C cohort (≥ 18 years) includes patients with any encounter after 1/1/2020 with SARS-CoV-2 laboratory tests. Detailed electronic medical records are centralized and harmonized across health-care organizations (34 sites). COVID-19 diagnosis was defined by RT-PCR or antibody testing. HIV infection was defined by standard diagnostic codes within 2 years prior to COVID-19 testing. Descriptive statistics and multivariable logistic regression were utilized to compare COVID-19 positivity and HIV status by patient's race/ethnicity. Over 2.1 million patients were captured in the N3C as of 01/29/2021, of whom 372,716 (15%) were positive for COVID-19; 17,820 (0.7%) were PLWH of whom 2428 (13.6%) tested positive for COVID-19. COVID-19 positive PLWH were more likely to be 30+ years of age (90% vs. 70%; χ2 PLWH and minoritized communities, including NH-Black and Latinx or Hispanic adults, appear to be disproportionately impacted by the COVID-19 pandemic.
Identifiants
pubmed: 35306931
doi: 10.1177/09564624221074468
pmc: PMC8935143
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
462-466Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK117445
Pays : United States
Organisme : NCATS NIH HHS
ID : U24 TR002306
Pays : United States
Références
J Econ Race Policy. 2020;3(4):243-261
pubmed: 35300199
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Lancet. 2021 Mar 20;397(10279):1040-1042
pubmed: 33617773
J Int AIDS Soc. 2020 Nov;23(11):e25639
pubmed: 33222424
Ann Intern Med. 2021 Jan;174(1):127-129
pubmed: 32692931
Lancet HIV. 2021 Nov;8(11):e690-e700
pubmed: 34655550
J Am Med Inform Assoc. 2021 Mar 1;28(3):427-443
pubmed: 32805036
Am Health Drug Benefits. 2019 Jun-Jul;12(4):188-197
pubmed: 31428236
Lancet. 2021 Mar 20;397(10279):1095-1106
pubmed: 33617774
Lancet HIV. 2021 Jun;8(6):e334-e341
pubmed: 33933189
N Engl J Med. 2021 Feb 25;384(8):768-773
pubmed: 33326717
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
Health Aff (Millwood). 2021 Jun;40(6):870-878
pubmed: 33979192
Health Aff (Millwood). 2020 Sep;39(9):1624-1632
pubmed: 32663045